CN Patent

CN119606887A — 一种药物缓释微球组合物及其制备方法和应用

Assigned to Hubei Bio-Pharmaceutical Industrial Technological Institute Inc · Expires 2025-03-14 · 1y expired

What this patent protects

本发明提供一种药物缓释微球组合物及其制备方法和应用，所述药物缓释微球组合物包括：活性成分，第一丙交酯‑乙交酯和/或第二丙交酯‑乙交酯共聚物，和任选的其它药学上可接受的辅料。本发明制备所得药物缓释微球组合物形态圆整，载药量高，可以实现长期稳定释放，应用价值高。

USPTO Abstract

本发明提供一种药物缓释微球组合物及其制备方法和应用，所述药物缓释微球组合物包括：活性成分，第一丙交酯‑乙交酯和/或第二丙交酯‑乙交酯共聚物，和任选的其它药学上可接受的辅料。本发明制备所得药物缓释微球组合物形态圆整，载药量高，可以实现长期稳定释放，应用价值高。

Drugs covered by this patent

Risperdal (risperidone) · Johnson & Johnson (Janssen)

Patent Metadata

Patent number: CN119606887A
Jurisdiction: CN
Classification: —
Expires: 2025-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.